Parents of Kids With Spinal Muscular Atrophy Are Worried About Signing Them up for Clinical Trials
Source: Pixabay

Parents of Kids With Spinal Muscular Atrophy Are Worried About Signing Them up for Clinical Trials

According to a story from SMA News Today, a recent study has demonstrated that the parents of children with spinal muscular atrophy are often skeptical about enrolling their kids in…

Continue Reading Parents of Kids With Spinal Muscular Atrophy Are Worried About Signing Them up for Clinical Trials
Angelman Syndrome Treatment Being Developed is Awarded ‘Orphan Drug’ Status in the U.S.
Source: Pixabay

Angelman Syndrome Treatment Being Developed is Awarded ‘Orphan Drug’ Status in the U.S.

A new drug being developed to treat Angelman syndrome (AS) has just been approved for ‘orphan drug’ status in the U.S., reports GlobeNewswire. The drug, called GTX-101, works by activating the…

Continue Reading Angelman Syndrome Treatment Being Developed is Awarded ‘Orphan Drug’ Status in the U.S.
Investigational Gene Therapy for Spinal Muscular Atrophy Gets SAKIGAKE Designation
source: pixabay.com

Investigational Gene Therapy for Spinal Muscular Atrophy Gets SAKIGAKE Designation

According to a story from GlobeNewswire, The pharmaceutical company AveXis, Inc., a company that specializes in the development of gene therapies, recently announced that its candidate AVXS-101 was awarded SAKIGAKE…

Continue Reading Investigational Gene Therapy for Spinal Muscular Atrophy Gets SAKIGAKE Designation
Clinic Beats Slow Hospitals to be the First to Deliver Spinal Muscular Atrophy Drug in Michigan
source: pixabay.com

Clinic Beats Slow Hospitals to be the First to Deliver Spinal Muscular Atrophy Drug in Michigan

The day after Christmas in 2016 brought a post-Holiday surprise to many in the U.S. with spinal muscular atrophy. December 26, 2016 marked the day that Spinraza was approved by…

Continue Reading Clinic Beats Slow Hospitals to be the First to Deliver Spinal Muscular Atrophy Drug in Michigan
Spinraza, a New Drug For SMA Patients Might Be Available Sooner Than Later in the UK
Source: Pixabay

Spinraza, a New Drug For SMA Patients Might Be Available Sooner Than Later in the UK

There is new hope for patients and their families suffering from spinal muscular atrophy (SMA) reported AOL UK News. SMA is a physically debilitating and aggressive disease, and now a new…

Continue Reading Spinraza, a New Drug For SMA Patients Might Be Available Sooner Than Later in the UK
How to Help This Inspiring Non-Profit Supporting Families Facing Devastating Diagnoses
https://pixabay.com/en/book-heart-love-grains-sand-sea-2115176/

How to Help This Inspiring Non-Profit Supporting Families Facing Devastating Diagnoses

Earlier this year, Patient Worthy featured Ashley and her non-profit Love Not Lost – an organization that provides portrait sessions and photo albums for families dealing with a terminal illness…

Continue Reading How to Help This Inspiring Non-Profit Supporting Families Facing Devastating Diagnoses
AveXis, Gene Therapy Development Company, Expands Program
Source: Pixabay

AveXis, Gene Therapy Development Company, Expands Program

The gene therapy development company, AveXis, Incorporation, just announced that they will be expanding their clinical trial development program for the potential gene therapy treatment: AVXS-101, reported Globe News Wire.…

Continue Reading AveXis, Gene Therapy Development Company, Expands Program

SMA Angels Charity Ball

Spinal muscular atrophy (SMA) is a devastating, rare inherited disorder that causes muscle weakness and degeneration. There are four types of spinal muscular atrophy and currently there is no known cure…

Continue Reading SMA Angels Charity Ball

Scientists Grow Motor Neurons in the Lab, Offering New Hope to ALS and SMA Communities

Rare diseases like ALS and SMA cause damage to motor neurons. Often, these conditions lead to death, in part because muscles in the chest are wasted away and the patient…

Continue Reading Scientists Grow Motor Neurons in the Lab, Offering New Hope to ALS and SMA Communities